212 related articles for article (PubMed ID: 37113192)
21. Gastrointestinal Behçet's disease: a review.
Skef W; Hamilton MJ; Arayssi T
World J Gastroenterol; 2015 Apr; 21(13):3801-12. PubMed ID: 25852265
[TBL] [Abstract][Full Text] [Related]
22. Case Report: A Case of Intestinal Behçet's Disease Exhibiting Enhanced Expression of IL-6 and Forkhead Box P3 mRNA After Treatment With Infliximab.
Yoshikawa K; Watanabe T; Sekai I; Takada R; Hara A; Kurimoto M; Masuta Y; Otsuka Y; Yoshikawa T; Masaki S; Kamata K; Minaga K; Komeda Y; Chikugo T; Kudo M
Front Med (Lausanne); 2021; 8():679237. PubMed ID: 34055846
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome after surgery in a patient with intestinal Behçet's disease complicated by myelodysplastic syndrome and trisomy 8.
Mori Y; Iwamoto F; Ishida Y; Kuno T; Kobayashi S; Yoshida T; Yamaguchi T; Sato T; Sudo M; Ichikawa D; Enomoto N
Intest Res; 2020 Oct; 18(4):469-475. PubMed ID: 32388943
[TBL] [Abstract][Full Text] [Related]
24. Case of Behçet's disease complicated by oculomotor nerve palsy associated with internal carotid artery-posterior communicating artery aneurysm.
Yamaoka T; Murota H; Katayama I
J Dermatol; 2015 Mar; 42(3):315-7. PubMed ID: 25573207
[TBL] [Abstract][Full Text] [Related]
25. Rediscover the clinical value of small intestinal bacterial overgrowth in patients with intestinal Behçet's disease.
Jo JH; Park SJ; Cheon JH; Kim TI; Kim WH
J Gastroenterol Hepatol; 2018 Feb; 33(2):375-379. PubMed ID: 28666309
[TBL] [Abstract][Full Text] [Related]
26. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
Park J; Cheon JH
Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of capsule endoscopy for detecting small bowel lesions in patients with intestinal Behçet's disease.
Arimoto J; Endo H; Kato T; Umezawa S; Fuyuki A; Uchiyama S; Higurashi T; Ohkubo H; Nonaka T; Takeno M; Ishigatsubo Y; Sakai E; Matsuhashi N; Nakajima A
Dig Endosc; 2016 Mar; 28(2):179-85. PubMed ID: 26459917
[TBL] [Abstract][Full Text] [Related]
28. Behçet's Disease: A Radiological Review of Vascular and Parenchymal Pulmonary Involvement.
Giannessi C; Smorchkova O; Cozzi D; Zantonelli G; Bertelli E; Moroni C; Cavigli E; Miele V
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428928
[TBL] [Abstract][Full Text] [Related]
29. Chemokines and chemokine receptors in Behçet's disease.
Li Z; Cheng L; Zhan H; Li Y
Front Immunol; 2023; 14():1109147. PubMed ID: 36742301
[TBL] [Abstract][Full Text] [Related]
30. A20 Haploinsufficiency in a Chinese Patient With Intestinal Behcet's Disease-Like Symptoms: A Case Report.
Chen Y; Huang H; He Y; Chen M; Seidler U; Tian D; Xiao F
Front Immunol; 2020; 11():1414. PubMed ID: 32719680
[No Abstract] [Full Text] [Related]
31. Behçet's Disease and Tuberculosis: A Complex Relationship.
Freitas SM; Marques JS; Grilo A; Gomes R; Gonçalves FM
Eur J Case Rep Intern Med; 2020; 7(2):001354. PubMed ID: 32133306
[TBL] [Abstract][Full Text] [Related]
32. [Diagnosis of intestinal Behçet's disease].
Cheon JH; Shin SJ; Kim SW; Lee KM; Kim JS; Kim WH;
Korean J Gastroenterol; 2009 Mar; 53(3):187-93. PubMed ID: 19835220
[TBL] [Abstract][Full Text] [Related]
33. Cluster analysis of paediatric Behçet's disease: Data from The Pediatric Rheumatology Academy-Research Group.
Demir F; Sönmez HE; Bağlan E; Akgün Ö; Coşkuner T; Yener GO; Öztürk K; Çakan M; Karadağ ŞG; Özdel S; Ayaz NA; Sözeri B
Mod Rheumatol; 2023 Apr; 33(3):574-578. PubMed ID: 35534229
[TBL] [Abstract][Full Text] [Related]
34. Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet's disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants.
Watanabe K; Tanida S; Inoue N; Kunisaki R; Kobayashi K; Nagahori M; Arai K; Uchino M; Koganei K; Kobayashi T; Takeno M; Ueno F; Matsumoto T; Mizuki N; Suzuki Y; Hisamatsu T
J Gastroenterol; 2020 Jul; 55(7):679-700. PubMed ID: 32377946
[TBL] [Abstract][Full Text] [Related]
35. Intestinal Behçet's Disease with Primary Myelofibrosis Involving Trisomy 8.
Narazaki T; Shiratsuchi M; Tsuda M; Tsukamoto Y; Muta H; Masuda T; Kimura D; Takamatsu A; Nakanishi R; Oki E; Fujiwara M; Oda Y; Nakashima Y; Ogawa Y
Acta Haematol; 2019; 142(4):253-256. PubMed ID: 31291615
[TBL] [Abstract][Full Text] [Related]
36. The Efficacy of Medium- to Long-term Anti-TNF-α Antibody-based Maintenance Therapy in Behçet's Disease Patients with Intestinal Lesions.
Kambayashi H; Omori T; Saito S; Murasugi S; Kashiwagi H; Ito A; Yonezawa M; Nakamura S; Tokushige K
Intern Med; 2020; 59(19):2343-2351. PubMed ID: 32999263
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of the NLRP3 inflammasome components in patients with Behçet's disease.
Kim EH; Park MJ; Park S; Lee ES
J Inflamm (Lond); 2015; 12():41. PubMed ID: 26136643
[TBL] [Abstract][Full Text] [Related]
38. Mucocutaneous manifestations of Behçet's disease: Pathogenesis and management from perspectives of vasculitis.
Kim D; Nakamura K; Kaneko F; Alpsoy E; Bang D
Front Med (Lausanne); 2022; 9():987393. PubMed ID: 36530905
[TBL] [Abstract][Full Text] [Related]
39. Focus on neuro-Behçet's disease: A review.
Caruso P; Moretti R
Neurol India; 2018; 66(6):1619-1628. PubMed ID: 30504554
[TBL] [Abstract][Full Text] [Related]
40. Hemoptysis Resolution with Rituximab in Behçet's Disease: A Case Report.
Jamaati H; Eskandari R; Sharif-Kashani B; Haghgoo R; Dastan F
Tanaffos; 2022 Mar; 21(3):401-404. PubMed ID: 37025315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
